Item 5.07 Submission of Matters to a Vote of Security Holders




On December 8, 2022, Medtronic plc, a public limited company organized under the
laws of Ireland (the "Company"), held its 2022 Annual General Meeting of
Shareholders in order to: (1) elect, by separate resolutions, eleven directors,
each to hold office until the 2023 Annual General Meeting of the Company and
until his or her successor is elected; (2) ratify, in a non-binding vote, the
appointment of PricewaterhouseCoopers LLP as the Company's independent auditor
for fiscal year 2023 and authorize, in a binding vote, the Company's Board of
Directors, acting through the Audit Committee, to set the auditor's
remuneration; (3) approve, in a non-binding advisory vote, named executive
officer compensation; (4) renew the Board's authority to issue shares; (5) renew
the Board's authority to opt out of pre-emption rights; and (6) authorize the
Company and any subsidiary of the Company to make overseas market purchases of
Medtronic ordinary shares.

At the close of business on October 11, 2022, the record date of the Annual
General Meeting, 1,330,070,251 Company ordinary shares were outstanding and
entitled to vote. The holders of a total of 1,160,421,233 ordinary shares were
present at the Annual General Meeting, either in person or by proxy, which total
was not less than a majority of the issued and outstanding ordinary shares
entitled to vote and thus constituted a quorum.

The final voting results and the votes used to determine the results for each proposal are set forth below:

1.The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2023 Annual General Meeting of the Company and until his or her successor is elected, as follows:



                                            FOR                         AGAINST                      ABSTAIN                    BROKER NON-VOTE
Richard H. Anderson                        982,165,958                  61,475,254                      831,052                   115,948,969
Craig Arnold                             1,006,424,719                  28,982,687                    9,064,858                   115,948,969
Scott C. Donnelly                        1,023,458,233                  20,095,049                      918,982                   115,948,969
Lidia L. Fonseca                         1,027,825,711                  15,881,098                      765,455                   115,948,969
Andrea J. Goldsmith, Ph.D.               1,040,386,088                   3,158,654                      927,522                   115,948,969
Randall J. Hogan, III                    1,034,757,456                   8,853,730                      861,078                   115,948,969
Kevin E. Lofton                          1,040,312,283                   3,322,096                      837,885                   115,948,969
Geoffrey S. Martha                         966,120,676                  71,626,975                    6,724,613                   115,948,969
Elizabeth G. Nabel, M.D.                   910,568,825                 133,144,537                      758,902                   115,948,969
Denise M. O'Leary                          953,636,260                  89,936,614                      899,390                   115,948,969
Kendall J. Powell                          939,339,071                 104,313,760                      819,433                   115,948,969



2. The shareholders ratified, in a non-binding vote, the appointment of
PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year
2023 and authorized, in a binding vote, the Company's Board of Directors, acting
through the Audit Committee, to set the auditor's remuneration.
       FOR             AGAINST         ABSTAIN

1,069,480,945 89,379,651 1,560,637

3. The shareholders approved, on a non-binding advisory basis, the compensation awarded to the Company's named executive officers.



     FOR            AGAINST         ABSTAIN       BROKER NON-VOTE
 972,415,707       69,940,489      2,116,068        115,948,969





--------------------------------------------------------------------------------

4. The shareholders approved renewal of the Board's authority to issue shares.
       FOR             AGAINST         ABSTAIN
  1,146,144,000       11,969,471      2,307,762


5. The shareholders approved renewal of the Board's authority to opt out of
pre-emption rights.

       FOR             AGAINST         ABSTAIN
  1,136,000,204       21,877,612      2,543,417

6. The shareholders approved authorization of the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.



       FOR             AGAINST         ABSTAIN
  1,129,189,149       27,068,953      4,163,131

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses